Physician
Cardiology
Dr. William B. Hillegass, MD
|
|
Give Review
William B. Hillegass is an expert in the field of Cardiology. He studied medicine at Harvard Medical School. Harvard Medical School is a top medical university. Harvard Medical School is ranked 1/12 in Research/PrimaryCare. He has 2 awards "Regional Top Doctor" and "Fellow (FACC)". William Hillegass is a published physician as well. He has 58 publications published. The latest was: Percutaneous coronary intervention: Ever closer to real world silver bullets!? He accepts Medicare payments and is listed with Medicare.gov.
Publications
- Percutaneous Coronary intervention: Ever closer to real world silver bullets!?
- Can femoral access bleeding outcomes be improved?
- Optimal DAPT duration: Each in their own time.
- Republished: The association between inflammatory markers, serum lipids and the risk of cardiovascular events in patients with rheumatoid arthritis.
- The learning curve for transradial percutaneous Coronary intervention among operators in the United States: a study from the national cardiovascular data registry.
- The association between inflammatory markers, serum lipids and the risk of cardiovascular events in patients with rheumatoid arthritis.
- Thromboaspiration and IIb/IIIa therapy in STEMI: Abciximab redux?
- Stent paleology: Diabetic lessons from extinct stents.
- Adoption of radial access and comparison of outcomes to femoral access in percutaneous Coronary intervention: an updated report from the national cardiovascular data r...
- Diabetes and everolimus-eluting stents: Good offense scores but defense wins tough games.
- Long-term outcomes of older diabetic patients after percutaneous Coronary stenting in the United States: a report from the National Cardiovascular Data Registry, 2004 ...
- Saphenous vein grafts: Two substrates, two treatments?
- Benefit of renal Artery stenting: Is on-target therapy the observational bias?
- Rotational atherectomy for heavily calcified unprotected left main Disease: Proceed with caution.
- Implicit rationing of percutaneous Coronary intervention: The left main test case.
- Diabetes and percutaneous Coronary intervention drug-eluting: Stents whenever feasible.
- Shock and age: The role of an early invasive strategy.
- Quality assessment and improvement in interventional cardiology: A position statement of the Society of Cardiovascular Angiography and Interventions, part 1: Standards...
- Quality assessment and improvement in interventional cardiology: A position statement of the society of cardiovascular angiography and interventions, Part II: Public r...
- A full toolbox fixes the roadblocks.
- Review: Third-generation P2Y12 inhibitors reduce mortality after PCI more than clopidogrel.
- DES in SVGs: safe and at least short-term effective.
- High glycemic stenting menu.
- Drug-eluting or bare metal stents for diabetics: clinical judgment still wins.
- The Holy Grail for DES: does efficacy translate into real world effectiveness?
- Which DES for diabetics? Round 1: A draw. Round 2: Everolimus leading?
- Bifurcation stenting: a commitment to always kiss.
- Treatment of refractory iatrogenic femoral artery pseudoAneurysm with a vascular closure device.
- Length matters: outcomes of superficial femoral Artery (SFA) endovascular interventions.
- As goes the access, so goes the intervention?
- The modern axis of peri-procedural evil.
- ACP Journal Club. Prasugrel prevented ischemic events compared with clopidogrel in patients having PCI for STEMI.
- A third dimension to uncloud the funnel plot of operator quality.
- Pretreatment with nitroprusside for microcirculatory protection in saphenous vein graft interventions.
- Vascular changes and black hole phenomenon after Coronary brachytherapy: a pathologically distinct entity.
- Prasugrel reduced ischemic outcomes more than did clopidogrel in patients receiving stents for ACS.
- DES in saphenous bypass grafts: A treatment in vain?
- Review: late percutaneous Coronary intervention after AMI improves survival more than optimal medical therapy.
- Aspirin was cost-effective for primary prevention of cardiovascular events in older women at moderate risk.
- Ruptured giant right Coronary artery aneurysm percutaneously plugged.
- Urgent revascularization with PCI was more cost-effective than CABG in medically refractory, high-risk Myocardial ischemia.
- First human case description of TandemHeart-assisted high-risk percutaneous balloon Aortic valvuloplasty using bivalirudin anticoagulation.
- Severe, diffuse Coronary artery spasm after drug-eluting stent placement.
- Review: evidence supporting reduced death and reinfarction by percutaneous Coronary intervention after thrombolysis is inconclusive.
- Rescue angioplasty reduced cardiovascular and cerebrovascular outcomes in Acute MI after failed thrombolytic therapy.
- Prophylactic implantable cardioverter-defibrillators increased life expectancy with an acceptable cost-effectiveness ratio.
- Invasive strategy within 24 hours of thrombolysis reduced death, nonfatal reInfarction, and ischemia-induced revascularization in STEMI.
- Cypher drug-eluting stent treatment of tibioperoneal obstructive Disease: a case report.
- High-dose atorvastatin was superior to standard-dose pravastatin for reducing death or major cardiovascular events in Acute coronary syndromes.
- Long-term follow-up of brachytherapy for treatment of allograft in-stent restenosis.
- Review: low-molecular-weight heparin is effective and safe in the Acute coronary syndromes.
- Treatment of in-stent restenosis in a gastroepiploic artery Coronary bypass graft with brachytherapy.
- An early invasive strategy reduced death, Myocardial infarction, and hospital readmissions at 2 years in unstable CAD.
- An interventional strategy was better than a conservative strategy in unstable Angina or non-ST-elevation MI.
- Relationship between heparin anticoagulation and clinical outcomes in Coronary stent intervention: observations from the ESPRIT trial.
- Cardiac resynchronization was effective for moderate-to-severe Heart failure with intraventricular conduction delay.
- Relationship between activated clotting time during percutaneous intervention and subsequent bleeding complications.
Schools
Harvard Medical School
Brigham and Women39s Hospital
Duke University Med Center
Procedures Preformed
- Cardiac Catheterization (incl. Coronary Angiography)
- Cardiac Imaging
- Cardiac MRI (Magnetic Resonance Imaging) of Heart or Chest
- Cardiac Myocardial Perfusion Imaging
- View All
Conditions Treated
- Angina and Acute Coronary Syndrome
- Aortic Aneurysm
- Aortic Valve Disease
- Arrhythmias (incl. Atrial Fibrillation)
- View All
Doctors Specialties
- Cardiology
- Interventional Cardiology
Accepted Insurances
Awards
- Regional Top Doctor
- Fellow (FACC)
Education
-
Duke University Hospital -
Brigham and Women's Hospital -
Harvard Medical School
Drug Facts
| NPI NUMBER | 1619906112 | |
| NPPES Provider LastName | HILLEGASS | |
| NPPES Provider FirstName | WILLIAM | |
| NPPES Provider ZIPCode | 350078740 | |
| NPPES Provider State | AL | |
| Specialty Description | Cardiology | |
| Total Claim Count | 197.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1619906112 |
| Last Name Of The Provider | HILLEGASS |
| First Name Of The Provider | WILLIAM |
| View All |
Similar Doctors
|
Dr. Luis D. Meggo Quiroz, MD |
|
Dr. Juan M. Bernal, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gian-Carlo Giove, MD |
|
|
Dr. Alan S. Gertler, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Anabela A. Simon-Lee, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joshua N. Cockrell, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Oscar J. Booker, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Leland W. Eaton, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Byron D. Jones, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ferdinand Urthaler, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Gregory A. Payne, MD
This Doctor is OpenDoctor Recommended.
|